1. Home
  2. IMNM vs GIS Comparison

IMNM vs GIS Comparison

Compare IMNM & GIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Immunome Inc.

IMNM

Immunome Inc.

HOLD

Current Price

$18.25

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Logo General Mills Inc.

GIS

General Mills Inc.

HOLD

Current Price

$33.13

Market Cap

18.5B

ML Signal

HOLD

Company Overview

Basic Information
Metric
IMNM
GIS
Founded
2006
1866
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Packaged Foods
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
18.5B
IPO Year
2020
2003

Fundamental Metrics

Financial Performance
Metric
IMNM
GIS
Price
$18.25
$33.13
Analyst Decision
Strong Buy
Hold
Analyst Count
10
16
Target Price
$32.80
$42.07
AVG Volume (30 Days)
1.2M
8.9M
Earning Date
05-08-2026
03-18-2026
Dividend Yield
N/A
7.08%
EPS Growth
51.40
N/A
EPS
N/A
3.56
Revenue
$6,941,000.00
$2,037,800,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$1,127.34
N/A
P/E Ratio
N/A
$9.32
Revenue Growth
N/A
4.11
52 Week Low
$7.96
$31.75
52 Week High
$27.65
$54.18

Technical Indicators

Market Signals
Indicator
IMNM
GIS
Relative Strength Index (RSI) 37.11 43.11
Support Level $16.81 $32.20
Resistance Level $19.16 $34.49
Average True Range (ATR) 0.91 0.92
MACD -0.12 0.16
Stochastic Oscillator 11.10 42.77

Price Performance

Historical Comparison
IMNM
GIS

About IMNM Immunome Inc.

Immunome Inc is a biotechnology company focused on developing first-in-class targeted oncology therapies. The company specializes in the discovery, design, development, manufacturing, and commercialization of antibody-drug conjugates and other oncology therapeutics. Its pipeline includes varegacestat, an investigational oral gamma secretase inhibitor that reported positive topline results in the Phase 3 RINGSIDE trial for progressing desmoid tumors; IM-1021, a ROR1 antibody-drug conjugate under evaluation in a Phase 1 trial; and IM-3050, a FAP-targeted radioligand therapy with IND clearance and a planned Phase 1 trial. The company is also advancing preclinical solid tumor ADCs, including IM-1617, IM-1340, and IM-1335.

About GIS General Mills Inc.

General Mills is a global packaged-food company that produces snacks, cereal, convenient meals, dough, baking mixes and ingredients, pet food, and superpremium ice cream. Its largest brands are Nature Valley, Cheerios, Old El Paso, Pillsbury, Betty Crocker, Blue Buffalo, and Haagen-Dazs. In fiscal 2025, 81% of its revenue was derived from the United States, although the company also operates in Canada, Europe, Australia, Asia, and Latin America. Although most of General Mills' products are sold through retail stores to consumers, the company also sells products to the foodservice channel and the commercial baking industry.

Share on Social Networks: